Universe Capital Expenditures from 2010 to 2025
| UPC Stock | USD 4.85 0.35 7.78% |
Capital Expenditures | First Reported 2017-12-31 | Previous Quarter 43.5 K | Current Value 67.7 K | Quarterly Volatility 1.8 M |
Check Universe Pharmaceuticals financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Universe Pharmaceuticals' main balance sheet or income statement drivers, such as Tax Provision of 1.6 M, Depreciation And Amortization of 413.1 K or Interest Expense of 153.8 K, as well as many indicators such as Price To Sales Ratio of 1.75, Dividend Yield of 0.0096 or PTB Ratio of 1.43. Universe financial statements analysis is a perfect complement when working with Universe Pharmaceuticals Valuation or Volatility modules.
Universe | Capital Expenditures |
Latest Universe Pharmaceuticals' Capital Expenditures Growth Pattern
Below is the plot of the Capital Expenditures of Universe Pharmaceuticals over the last few years. Capital Expenditures are funds used by Universe Pharmaceuticals to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Universe Pharmaceuticals operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software. It is Universe Pharmaceuticals' Capital Expenditures historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Universe Pharmaceuticals' overall financial position and show how it may be relating to other accounts over time.
| Capital Expenditures | 10 Years Trend |
|
Capital Expenditures |
| Timeline |
Universe Capital Expenditures Regression Statistics
| Arithmetic Mean | 944,451 | |
| Geometric Mean | 128,205 | |
| Coefficient Of Variation | 355.42 | |
| Mean Deviation | 1,573,347 | |
| Median | 145,095 | |
| Standard Deviation | 3,356,768 | |
| Sample Variance | 11.3T | |
| Range | 13.5M | |
| R-Value | 0.13 | |
| Mean Square Error | 11.9T | |
| R-Squared | 0.02 | |
| Significance | 0.64 | |
| Slope | 90,493 | |
| Total Sum of Squares | 169T |
Universe Capital Expenditures History
About Universe Pharmaceuticals Financial Statements
Universe Pharmaceuticals stakeholders use historical fundamental indicators, such as Universe Pharmaceuticals' Capital Expenditures, to determine how well the company is positioned to perform in the future. Although Universe Pharmaceuticals investors may analyze each financial statement separately, they are all interrelated. For example, changes in Universe Pharmaceuticals' assets and liabilities are reflected in the revenues and expenses on Universe Pharmaceuticals' income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Universe Pharmaceuticals. Please read more on our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Capital Expenditures | 50.8 K | 48.3 K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| ZLAB | Zai Lab | |
| ASLE | AerSale Corp | |
| ATS | AT S Austria |
Check out the analysis of Universe Pharmaceuticals Correlation against competitors. For information on how to trade Universe Stock refer to our How to Trade Universe Stock guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Universe Pharmaceuticals. If investors know Universe will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Universe Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.82) | Earnings Share -3.1 K | Revenue Per Share | Quarterly Revenue Growth (0.30) | Return On Assets |
The market value of Universe Pharmaceuticals is measured differently than its book value, which is the value of Universe that is recorded on the company's balance sheet. Investors also form their own opinion of Universe Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Universe Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Universe Pharmaceuticals' market value can be influenced by many factors that don't directly affect Universe Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Universe Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Universe Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Universe Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.